Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 345

1.

Peritoneal carcinomatosis is multifaceted, treatment requires expertise and collaboration with other health care personnel: New avenues of research are open.

Pocard M.

J Visc Surg. 2019 Oct 11. pii: S1878-7886(19)30140-7. doi: 10.1016/j.jviscsurg.2019.09.006. [Epub ahead of print] No abstract available.

PMID:
31611177
2.

Optimization of a low pressure plasma process for fabrication of a Drug Delivery System (DDS) for cancer treatment.

Baitukha A, Al-Dybiat I, Valinataj-Omran A, Pulpytel J, Pocard M, Mirshahi M, Arefi-Khonsari F.

Mater Sci Eng C Mater Biol Appl. 2019 Dec;105:110089. doi: 10.1016/j.msec.2019.110089. Epub 2019 Aug 15.

PMID:
31546399
3.

Evaluation of a new histological grading system for assessing the response to chemotherapy of peritoneal metastases from colorectal cancer: A mouse model study.

Taibi A, Lo Dico R, Kaci R, Naneix AL, Malgras B, Mathonnet M, Pocard M.

Eur J Surg Oncol. 2019 Sep 12. pii: S0748-7983(19)30674-2. doi: 10.1016/j.ejso.2019.09.008. [Epub ahead of print]

PMID:
31540756
4.

Bowel obstruction due to a right paraduodenal hernia with midgut malrotation.

Peru N, Jouvin I, Pocard M.

J Visc Surg. 2019 Sep 12. pii: S1878-7886(19)30133-X. doi: 10.1016/j.jviscsurg.2019.08.008. [Epub ahead of print]

PMID:
31522910
5.

Management of colorectal peritoneal metastases: Expert opinion.

Abboud K, André T, Brunel M, Ducreux M, Eveno C, Glehen O, Goéré D, Gornet JM, Lefevre JH, Mariani P, Pinto A, Quenet F, Sgarbura O, Ychou M, Pocard M.

J Visc Surg. 2019 Aug 26. pii: S1878-7886(19)30127-4. doi: 10.1016/j.jviscsurg.2019.08.002. [Epub ahead of print]

PMID:
31466831
6.

MESOTIP: Phase II multicenter randomized trial evaluating the association of PIPAC and systemic chemotherapy vs. systemic chemotherapy alone as 1st-line treatment of malignant peritoneal mesothelioma.

Sgarbura O, Gourgou S, Tosi D, Bakrin N, Bouazza N, Delaine S, De Forges H, Pocard M, Quénet F.

Pleura Peritoneum. 2019 Jun 27;4(2):20190010. doi: 10.1515/pp-2019-0010. eCollection 2019 Jun 1.

7.

Hyperthermic intraperitoneal chemotherapy with cisplatin and mitomycin C for colorectal cancer peritoneal metastases: A systematic review of the literature.

Pinto A, Pocard M.

Pleura Peritoneum. 2019 May 29;4(2):20190006. doi: 10.1515/pp-2019-0006. eCollection 2019 Jun 1. Review.

8.

Erratum to "Cephalic vein portacath placement technique" [J. Visc. Surg. 156 (2019) 239-243].

Jouvin I, Pocard M, Najah H.

J Visc Surg. 2019 Sep;156(4):371. doi: 10.1016/j.jviscsurg.2019.06.011. Epub 2019 Jul 23. No abstract available.

PMID:
31350203
9.

The role of single-incision laparoscopic peritoneal exploration in the management of patients with peritoneal metastases.

Najah H, Malgras B, Dohan A, Gronnier C, Eveno C, Pocard M.

Surg Endosc. 2019 Jul 18. doi: 10.1007/s00464-019-06984-8. [Epub ahead of print]

PMID:
31321535
10.

Differential gene expression in growth factors, epithelial mesenchymal transition and chemotaxis in the diffuse type compared with the intestinal type of gastric cancer.

Perrot-Applanat M, Vacher S, Pimpie C, Chemlali W, Derieux S, Pocard M, Bieche I.

Oncol Lett. 2019 Jul;18(1):674-686. doi: 10.3892/ol.2019.10392. Epub 2019 May 21.

11.

[CHIP and ovarian cancer].

Lécuru F, Bakrin N, Classe JM, Colombo PE, Ferron G, Freyer G, Glehen O, Gouy S, Huchon C, Narducci F, Pocard M, Pomel C, Rouzier R.

Gynecol Obstet Fertil Senol. 2019 Sep;47(9):617-618. doi: 10.1016/j.gofs.2019.06.007. Epub 2019 Jun 26. French. No abstract available.

PMID:
31252153
12.

Targeting the differentiation of gastric cancer cells (KATO‑III) downregulates epithelial‑mesenchymal and cancer stem cell markers.

Shah S, Pocard M, Mirshahi M.

Oncol Rep. 2019 Aug;42(2):670-678. doi: 10.3892/or.2019.7198. Epub 2019 Jun 12.

13.

Can we cure patients with abdominal Desmoplastic Small Round Cell Tumor? Results of a retrospective multicentric study on 100 patients.

Honoré C, Delhorme JB, Nassif E, Faron M, Ferron G, Bompas E, Glehen O, Italiano A, Bertucci F, Orbach D, Pocard M, Quenet F, Blay JY, Carrere S, Chevreau C, Mir O, Le Cesne A; French Network for Rare Peritoneal Malignancies (RENAPE), French Sarcoma Clinical Network (NETSARC).

Surg Oncol. 2019 Jun;29:107-112. doi: 10.1016/j.suronc.2019.04.002. Epub 2019 Apr 15.

PMID:
31196472
14.

Cephalic vein portacath placement technique.

Jouvin I, Pocard M, Najah H.

J Visc Surg. 2019 Jun;156(3):239-243. doi: 10.1016/j.jviscsurg.2018.11.006. Epub 2019 May 29. No abstract available. Erratum in: J Visc Surg. 2019 Sep;156(4):371.

PMID:
31153802
15.

Oxaliplatin use in pressurized intraperitoneal aerosol chemotherapy (PIPAC) is safe and effective: A multicenter study.

Sgarbura O, Hübner M, Alyami M, Eveno C, Gagnière J, Pache B, Pocard M, Bakrin N, Quénet F.

Eur J Surg Oncol. 2019 May 9. pii: S0748-7983(19)30445-7. doi: 10.1016/j.ejso.2019.05.007. [Epub ahead of print]

PMID:
31092362
16.

Cytoreductive Surgery With or Without Hyperthermic Intraperitoneal Chemotherapy for Gastric Cancer With Peritoneal Metastases (CYTO-CHIP study): A Propensity Score Analysis.

Bonnot PE, Piessen G, Kepenekian V, Decullier E, Pocard M, Meunier B, Bereder JM, Abboud K, Marchal F, Quenet F, Goere D, Msika S, Arvieux C, Pirro N, Wernert R, Rat P, Gagnière J, Lefevre JH, Courvoisier T, Kianmanesh R, Vaudoyer D, Rivoire M, Meeus P, Passot G, Glehen O; FREGAT and BIG-RENAPE Networks.

J Clin Oncol. 2019 Aug 10;37(23):2028-2040. doi: 10.1200/JCO.18.01688. Epub 2019 May 14.

PMID:
31084544
17.

Recurrence of pseudomyxoma peritonei after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.

Mercier F, Dagbert F, Pocard M, Goéré D, Quenet F, Wernert R, Dumont F, Brigand C, Passot G, Glehen O; RENAPE Network.

BJS Open. 2018 Sep 27;3(2):195-202. doi: 10.1002/bjs5.97. eCollection 2019 Apr.

18.

Photodynamic therapy and photothermal therapy for the treatment of peritoneal metastasis: a systematic review.

Pinto A, Pocard M.

Pleura Peritoneum. 2018 Dec 18;3(4):20180124. doi: 10.1515/pp-2018-0124. eCollection 2018 Dec 1. Review.

19.
20.
21.

Intraperitoneal aerosolization of albumin-stabilized paclitaxel nanoparticles (Abraxane™) for peritoneal carcinomatosis - a phase I first-in-human study.

Van De Sande L, Graversen M, Hubner M, Pocard M, Reymond M, Vaira M, Cosyns S, Willaert W, Ceelen W.

Pleura Peritoneum. 2018 Jun 8;3(2):20180112. doi: 10.1515/pp-2018-0112. eCollection 2018 Jun 1.

22.

Post-operative wall shear stress in the superior mesenteric artery: Biomarker of long term outcome in patients with residual disease after incomplete cytoreductive surgery for pseudomyxoma peritonei.

Barral M, El Sanharawi I, Eveno C, Dohan A, Launay JM, Lo Dico R, Pocard M, Bonnin P.

Eur J Surg Oncol. 2019 Sep;45(9):1727-1733. doi: 10.1016/j.ejso.2019.03.001. Epub 2019 Mar 6.

PMID:
30871885
23.

High Expression of HLA-G in Ovarian Carcinomatosis: The Role of Interleukin-1β.

Ullah M, Azazzen D, Kaci R, Benabbou N, Pujade Lauraine E, Pocard M, Mirshahi M.

Neoplasia. 2019 Mar;21(3):331-342. doi: 10.1016/j.neo.2019.01.001. Epub 2019 Feb 22.

24.

PIPAC: 8 key points for a good practice with video.

Mariano G, Pocard M, Eveno C.

J Visc Surg. 2019 Apr;156(2):169-171. doi: 10.1016/j.jviscsurg.2019.01.006. Epub 2019 Feb 13. No abstract available.

PMID:
30770295
25.

Preoperative assessment of splenic involvement in patients with peritoneal carcinomatosis with CT and MR imaging.

Berthelin MA, Barral M, Eveno C, Rousset P, Dautry R, Pocard M, Soyer P, Dohan A.

Eur J Radiol. 2019 Jan;110:60-65. doi: 10.1016/j.ejrad.2018.11.022. Epub 2018 Nov 20.

PMID:
30599874
26.

Iterative cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy for colorectal peritoneal metastases: A multi-institutional experience.

Alzahrani NA, Valle SJ, Fisher OM, Sugarbaker PH, Yonemura Y, Glehen O, Goere D, Honore C, Brigand C, de Hingh I, Verwaal VJ, Deraco M, Baratti D, Kusamura S, Pocard M, Piso P, Maerz L, Marchal F, Moran B, Levine EA, Dumont F, Pezet D, Abboud K, Kozman MA, Liauw W, Morris DL; Peritoneal Surface Oncology Group International (PSOGI) and Big-RENAPE groups.

J Surg Oncol. 2019 Mar;119(3):336-346. doi: 10.1002/jso.25277. Epub 2018 Dec 16.

PMID:
30554404
27.

Echo-guided percutaneous approach to the internal jugular vein for implantable portacath.

Pinto A, Pocard M.

J Visc Surg. 2019 Apr;156(2):147-151. doi: 10.1016/j.jviscsurg.2018.11.003. Epub 2018 Nov 28. No abstract available.

PMID:
30503156
28.

Resection of small bowel adenocarcinoma metastases: Results of the ARCAD-NADEGE cohort study.

Rompteaux P, Gagnière J, Gornet JM, Coriat R, Baumgaertner I, Lecomte T, Afchain P, Zaanan A, Pocard M, Bachet JB, Bonichon-Lamichhane N, Bouché O, Faucheron JL, Forestier J, Lecaille C, Manfredi S, Tougeron D, Terrebonne E, Chehimi M, Villing AL, Sarda C, Legoux JL, Benamouzig R, Aparicio T.

Eur J Surg Oncol. 2019 Mar;45(3):331-335. doi: 10.1016/j.ejso.2018.11.012. Epub 2018 Nov 22.

PMID:
30501999
29.

Deloyers procedure.

Jouvin I, Pocard M, Najah H.

J Visc Surg. 2018 Dec;155(6):493-501. doi: 10.1016/j.jviscsurg.2018.10.001. Epub 2018 Nov 16. No abstract available.

PMID:
30455107
30.

The close relationship between heparanase and epithelial mesenchymal transition in gastric signet-ring cell adenocarcinoma.

Shah S, Fourgeaud C, Derieux S, Mirshahi S, Contant G, Pimpie C, Lo Dico R, Soria J, Pocard M, Mirshahi M.

Oncotarget. 2018 Sep 18;9(73):33778-33787. doi: 10.18632/oncotarget.26042. eCollection 2018 Sep 18.

31.

Preoperative evaluation of small bowel complications in Crohn's disease: comparison of diffusion-weighted and contrast-enhanced MR imaging.

Barat M, Hoeffel C, Bouquot M, Jannot AS, Dautry R, Boudiaf M, Pautrat K, Kaci R, Camus M, Eveno C, Pocard M, Soyer P, Dohan A.

Eur Radiol. 2019 Apr;29(4):2034-2044. doi: 10.1007/s00330-018-5734-2. Epub 2018 Oct 9.

PMID:
30302591
32.

Left anterolateral thoracotomy with cross-clamping of the descending thoracic aorta and open cardiac massage to control massive intra-abdominal bleeding.

Peru N, Malgras B, Pocard M.

J Visc Surg. 2018 Oct;155(5):407-411. doi: 10.1016/j.jviscsurg.2018.07.007. Epub 2018 Aug 23. No abstract available.

PMID:
30146448
33.

Cytoreductive surgery and HIPEC improve survival compared to palliative chemotherapy for biliary carcinoma with peritoneal metastasis: A multi-institutional cohort from PSOGI and BIG RENAPE groups.

Amblard I, Mercier F, Bartlett DL, Ahrendt SA, Lee KW, Zeh HJ, Levine EA, Baratti D, Deraco M, Piso P, Morris DL, Rau B, Tentes AAK, Tuech JJ, Quenet F, Akaishi E, Pocard M, Yonemura Y, Lorimier G, Delroeux D, Villeneuve L, Glehen O, Passot G; PSOGI and BIG RENAPE working groups.

Eur J Surg Oncol. 2018 Sep;44(9):1378-1383. doi: 10.1016/j.ejso.2018.04.023. Epub 2018 Jun 19.

PMID:
30131104
34.

Impact of Combination Chemotherapy in Peritoneal Mesothelioma Hyperthermic Intraperitoneal Chemotherapy (HIPEC): The RENAPE Study.

Malgras B, Gayat E, Aoun O, Lo Dico R, Eveno C, Pautrat K, Delhorme JB, Passot G, Marchal F, Sgarbura O, Ferron G, Goéré D, Andre T, Pocard M; RENAPE Network.

Ann Surg Oncol. 2018 Oct;25(11):3271-3279. doi: 10.1245/s10434-018-6631-2. Epub 2018 Jul 5.

PMID:
29978366
35.

Inflammatory bowel disease drastically affects the prognosis of patients treated for peritoneal metastases with combined cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: A multicenter study.

Hammoudi N, Eveno C, Lambert J, Maillet M, Glehen O, Goere D, Lourenco N, Allez M, Aparicio T, Pocard M, Gornet JM; BIG-RENAPE working group.

Eur J Surg Oncol. 2018 Jun;44(6):799-804. doi: 10.1016/j.ejso.2018.03.006. Epub 2018 Mar 17.

PMID:
29650418
36.

Preoperative assessment of peritoneal carcinomatosis of colorectal origin.

Dohan A, Hobeika C, Najah H, Pocard M, Rousset P, Eveno C.

J Visc Surg. 2018 Sep;155(4):293-303. doi: 10.1016/j.jviscsurg.2018.01.002. Epub 2018 Mar 27. Review.

PMID:
29602696
37.

Hepatectomy increases metastatic graft and growth in an immunocompetent murine model of peritoneal metastases.

Lo Dico R, Tijeras-Raballand A, Bonnin P, Launay JM, Kaci R, Pimpie C, Malgras B, Dohan A, Lo Dico GM, Pocard M.

Eur J Surg Oncol. 2018 Jun;44(6):784-791. doi: 10.1016/j.ejso.2018.01.096. Epub 2018 Jan 31.

PMID:
29525466
38.

Preoperative detection of malignant liver tumors: Comparison of 3D-T2-weighted sequences with T2-weighted turbo spin-echo and single shot T2 at 1.5 T.

Barat M, Soyer P, Dautry R, Pocard M, Lo-Dico R, Najah H, Eveno C, Cassinotto C, Dohan A.

Eur J Radiol. 2018 Mar;100:7-13. doi: 10.1016/j.ejrad.2018.01.007. Epub 2018 Jan 11.

PMID:
29496082
39.

Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Metastases From a Small Bowel Adenocarcinoma: Multi-Institutional Experience.

Liu Y, Yonemura Y, Levine EA, Glehen O, Goere D, Elias D, Morris DL, Sugarbaker PH, Tuech JJ, Cashin P, Spiliotis JD, de Hingh I, Ceelen W, Baumgartner JM, Piso P, Katayama K, Deraco M, Kusamura S, Pocard M, Quenet F, Fushita S; BIG-RENAPE Group.

Ann Surg Oncol. 2018 May;25(5):1184-1192. doi: 10.1245/s10434-018-6369-x. Epub 2018 Feb 26.

40.

A late life-threatening complication of laparoscopic adjustable gastric banding.

Jouvin I, Barral M, Pocard M, Najah H.

Surgery. 2018 May;163(5):1186-1187. doi: 10.1016/j.surg.2018.01.007. Epub 2018 Feb 21. No abstract available.

PMID:
29475613
41.

Discontinuous Schedule of Bevacizumab in Colorectal Cancer Induces Accelerated Tumor Growth and Phenotypic Changes.

Becherirat S, Valamanesh F, Karimi M, Faussat AM, Launay JM, Pimpie C, Therwath A, Pocard M.

Transl Oncol. 2018 Apr;11(2):406-415. doi: 10.1016/j.tranon.2018.01.017. Epub 2018 Feb 20.

42.

CCL2/CCL5 secreted by the stroma induce IL-6/PYK2 dependent chemoresistance in ovarian cancer.

Pasquier J, Gosset M, Geyl C, Hoarau-Véchot J, Chevrot A, Pocard M, Mirshahi M, Lis R, Rafii A, Touboul C.

Mol Cancer. 2018 Feb 19;17(1):47. doi: 10.1186/s12943-018-0787-z.

43.

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for pseudomyxoma peritonei of appendicular and extra-appendicular origin.

Delhorme JB, Severac F, Averous G, Glehen O, Passot G, Bakrin N, Marchal F, Pocard M, Lo Dico R, Eveno C, Carrere S, Sgarbura O, Quenet F, Ferron G, Goéré D, Brigand C; French National Network of Peritoneal Surface Malignancies (RENAPE).

Br J Surg. 2018 May;105(6):668-676. doi: 10.1002/bjs.10716. Epub 2018 Feb 7.

PMID:
29412465
44.

Tumour spheres with inverted polarity drive the formation of peritoneal metastases in patients with hypermethylated colorectal carcinomas.

Zajac O, Raingeaud J, Libanje F, Lefebvre C, Sabino D, Martins I, Roy P, Benatar C, Canet-Jourdan C, Azorin P, Polrot M, Gonin P, Benbarche S, Souquere S, Pierron G, Nowak D, Bigot L, Ducreux M, Malka D, Lobry C, Scoazec JY, Eveno C, Pocard M, Perfettini JL, Elias D, Dartigues P, Goéré D, Jaulin F.

Nat Cell Biol. 2018 Mar;20(3):296-306. doi: 10.1038/s41556-017-0027-6. Epub 2018 Feb 5.

PMID:
29403038
45.

Angiogenic factor-driven inflammation promotes extravasation of human proangiogenic monocytes to tumours.

Sidibe A, Ropraz P, Jemelin S, Emre Y, Poittevin M, Pocard M, Bradfield PF, Imhof BA.

Nat Commun. 2018 Jan 24;9(1):355. doi: 10.1038/s41467-017-02610-0.

46.

High AHR expression in breast tumors correlates with expression of genes from several signaling pathways namely inflammation and endogenous tryptophan metabolism.

Vacher S, Castagnet P, Chemlali W, Lallemand F, Meseure D, Pocard M, Bieche I, Perrot-Applanat M.

PLoS One. 2018 Jan 10;13(1):e0190619. doi: 10.1371/journal.pone.0190619. eCollection 2018.

47.

What Is the most Important for Elite Control: Genetic Background of Patient, Genetic Background of Partner, both or neither? Description of Complete Natural History within a Couple of MSM.

Bendenoun M, Samri A, Avettand-Fènoël V, Cardinaud S, Descours B, Carcelain G, Mazeron MC, Bergmann JF, Urrutia A, Moris A, Rouzioux C, Simon F, Andre P, Pocard M, Dray X, Mourez T, Vieillard V, Autran B, Barin F, Sellier P.

EBioMedicine. 2018 Jan;27:51-60. doi: 10.1016/j.ebiom.2017.12.003. Epub 2017 Dec 7.

48.

Volvulus of the sigmoid colon is associated with hypotrophy of the left lateral segment of the liver and the absence of sigmoid diverticulum.

Barral M, Lassalle L, Dautry R, Eveno C, De Laveaucoupet J, Maitre S, Dohan A, Pocard M, Soyer P.

Diagn Interv Imaging. 2018 Apr;99(4):247-253. doi: 10.1016/j.diii.2017.08.003. Epub 2017 Nov 29.

49.

Prediction of Resectability in Pseudomyxoma Peritonei with a New CT Score.

Bouquot M, Dohan A, Gayat E, Barat M, Glehen O, Pocard M, Rousset P, Eveno C.

Ann Surg Oncol. 2018 Mar;25(3):694-701. doi: 10.1245/s10434-017-6275-7. Epub 2017 Nov 30.

PMID:
29192372
50.

Medical devices for treating peritoneal metastasis in low-income countries: is less more?

Pocard M.

Pleura Peritoneum. 2017 Dec 1;2(4):149-151. doi: 10.1515/pp-2017-0023. Epub 2017 Nov 23. No abstract available.

Supplemental Content

Loading ...
Support Center